GlaxoSmithKline PLC ADR (GSK) Insider Trading
- $76,153,352.00
- $392,064,435.00
- Nov. 25, 2024
- Plc Glaxosmithkline
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 25, 2024 | U.S. Congress Member <small>(R-GA)</small> | 0 | $34.15 | Buy | $0.00 | |
Sept. 27, 2024 | Major Shareholder | 2,791,930 | $8.00 | Buy | $22,335,440.00 | |
May 20, 2021 | Major Shareholder | 32,005,260 | $12.25 | Sell | $392,064,435.00 | |
July 21, 2020 | Director | 361,111 | $18.00 | Buy | $6,499,998.00 | |
Oct. 18, 2019 | Major Shareholder | 357,142 | $28.00 | Buy | $9,999,976.00 | |
Sept. 10, 2019 | Director | 177,777 | $45.00 | Buy | $7,999,965.00 | |
July 1, 2019 | Director | 333,333 | $15.00 | Buy | $4,999,995.00 | |
May 28, 2019 | Director | 385,714 | $14.00 | Buy | $5,399,996.00 | |
April 22, 2019 | Director | 325,000 | $18.00 | Buy | $5,850,000.00 | |
July 30, 2018 | Insider | 148,818 | $11.00 | Buy | $1,636,998.00 | |
July 17, 2018 | Major Shareholder | 80,000 | $12.50 | Buy | $1,000,000.00 | |
July 2, 2018 | Major Shareholder | 269,230 | $13.00 | Buy | $3,499,990.00 | |
Nov. 6, 2017 | Major Shareholder | 428,571 | $14.00 | Buy | $5,999,994.00 | |
Oct. 24, 2016 | Major Shareholder | 66,500 | $14.00 | Buy | $931,000.00 |
Insiders are both buying and selling GlaxoSmithKline PLC ADR stock.
The insider traders at GlaxoSmithKline PLC ADR are: Plc Glaxosmithkline, Marjorie Taylor Greene, and Plc Gsk
The most active insider trader at GlaxoSmithKline PLC ADR is Plc Glaxosmithkline with 12 trades.
Plc Glaxosmithkline has sold the most GlaxoSmithKline PLC ADR stock with a total value of $784,128,870.00.
Plc Glaxosmithkline has bought the most GlaxoSmithKline PLC ADR stock with a total value of $60,317,910.00.
The most recent insider trade for GlaxoSmithKline PLC ADR was on Nov. 25, 2024.
The single biggest insider buy for GlaxoSmithKline PLC ADR was from Plc Gsk with a total value of $22,335,440.00 on Sept. 27, 2024.
The single biggest insider sell for GlaxoSmithKline PLC ADR was from Plc Glaxosmithkline with a total value of $392,064,435.00 on May 20, 2021.